Febrile Neutropenia  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT02119715: A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy

Completed
2
182
RoW
Pegylated rhG-CSF 100μg/kg, HHPG-19K 100µg/kg, Pegylated rhG-CSF:150 μg/kg, HHPG-19K 150μg/kg, rhG-CSF 5 μg/kg/day, Jie Xin 5 μg/kg/day
Jiangsu HengRui Medicine Co., Ltd.
Breast Cancer, Neutropenia, Febrile Neutropenia
08/12
12/12
DIPE, NCT02005783: Study of Danggui Buxue Decoction in Preventing Neutropenia

Completed
2
50
RoW
DBD, Danggui Buxue Decoction, Epirubicin, Cyclophosphamide, Docetaxel
Shanghai Jiao Tong University School of Medicine
Grade 3/4 Neutropenia, Febrile Neutropenia
08/15
10/15

Download Options